Urolithiasis pp 261-262 | Cite as

Amino Acid Excretion in Urinary Calculous Disease

  • F. Hussain
  • P. P. Singh
  • A. K. Pendse


In more recent times, major stress has been placed on the role of inhibitors in urolithiasis. Most urines are supersaturated and high levels of stone promoters would induce spontaneous crystallization but for the presence of adequate amounts of inhibitors (1). However, all the inhibitor substances are yet to be clearly identified, and their relative contribution is to be decided. Amino acids are also reported to be inhibitors but their role is still not clear as contrary reports have appeared in the literature. A high prevalence of urinary stone disease in this region of India stimulated us to undertake various studies on urolithiasis. In the present paper, urinary excretion of amino acids in healthy normal subjects (NS) and stone formers (SF), and the influence of the different amino acids on an in vitro mineralization process are reported.


Normal Subject Stone Former Calcium Oxalate Renal Stone Renal Calculus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    LN Pyrah, Chemical substance in urine promoting or preventing renal stone, in: “Renal Calculus,” Springer Verlag, New York (1979).CrossRefGoogle Scholar
  2. 2.
    S Natelson, 1971, “Techniques of Clinical Biochemistry, 3rd Ed.,” Charles C. Thomas.Google Scholar
  3. 3.
    MG McGeown, The urinary excretion of amino acids in calculus patients, Clin. Sci. 18: 185 (1959).Google Scholar
  4. 4.
    BA Hum, RG Huntsman, H Lehmann, J Liddell, and AB Roos, Urinary amino acids and calcium in relation to renal stones and renal damage, Clin. Sci. 22: 195 (1962).Google Scholar
  5. 5.
    WC Thomas, Jr., MH Malagodi, and OM Rannert, 1981, Urinary excretion of amino acids by subjects with renal calculi, in: “Urolithiasis, Clinical and Basic Research,” LH Smith, WG Robertson, and B Finlayson, eds., Plenum Press, New York.Google Scholar
  6. 6.
    R Azoury, S Sarig, N Garti, and S Perlberg, Retaliation of calcium oxalate precipitation by glutamate oxaloacetate transaminase activity, Urol. Res. 10(4): 169 (1982).PubMedGoogle Scholar
  7. 7.
    PP Singh, D Verma, A Goyal, and AK Pendse, Hydroxyprolinuria in stone formers and the effect of cystone (a formulation of indigenous drugs) therapy, PROBE 15(4): 345 (1986).Google Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • F. Hussain
    • 1
  • P. P. Singh
    • 1
  • A. K. Pendse
    • 1
  1. 1.Departments of Biochemistry and SurgeryR.N.T. Medical CollegeUdaipurIndia

Personalised recommendations